RECURRENT/ METASTATIC NPC

Clinical trials for RECURRENT/ METASTATIC NPC explained in plain language.

Never miss a new study

Get alerted when new RECURRENT/ METASTATIC NPC trials appear

Sign up with your email to follow new studies for RECURRENT/ METASTATIC NPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Targeting antibody takes on Hard-to-Treat throat cancer

Disease control Recruiting now

This trial tests a new drug called JS207, a bispecific antibody that targets two proteins (PD1 and VEGF) involved in cancer growth and immune evasion. It is being studied in people with recurrent or metastatic nasopharyngeal carcinoma, a type of throat cancer, who have already tr…

Matched conditions: RECURRENT/ METASTATIC NPC

Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC

RECURRENT/ METASTATIC NPC

Get alerted when new RECURRENT/ METASTATIC NPC trials appear

Double-Targeting antibody takes on Hard-to-Treat throat cancer